Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Development of Antibacterial Drugs by Targeting Toll-Like Receptors

Author(s): Qun Xu, Gengzheng Zhu, Jing Li and Kui Cheng

Volume 17, Issue 3, 2017

Page: [270 - 277] Pages: 8

DOI: 10.2174/1568026616666160829161639

Price: $65

Abstract

The invading microbial pathogens are controlled by the rapid and effective innate immune responses sequentially formation of the long-lasting adaptive memories. Toll-like receptors (TLRs) play a vital role in innate and adaptive immune response by function as a bridge to modulate the immune response. Further, genetic studies in human or animals showed that regulation of TLR signaling contributes to the antibacterial efficacy, and developing novel reagent to modulate TLR related immune response becomes an interesting therapy method to against bacterial infections. Herein we review the recent developments of this area, focusing on the reagent of synthetic molecules, natural products and peptides (or proteins), as TLR-related antibacterial drugs.

Keywords: Antimicrobial, Toll-like receptor, Inflammation, Natural product, Peptide, Synthetic molecule.

« Previous Next »
Graphical Abstract


Rights & Permissions Print Cite
Article Metrics
50
3
1
© 2025 Bentham Science Publishers | Privacy Policy